All Resources

A short video of Professor Albanese O’Neil describing the benefits of early detection of T1D as discovered through early detection screening programs.

A short video of Professor Colin Dayan describing the current and potential future therapeutic options for managing T1D.

A short video from EASD 2025 exploring learnings from implementation of population-level T1D screening programs .

During the BR1DGE Symposium at the FIP 2025 titled “Shifting the Paradigm: Innovations in T1D Screening and Pharmacist-Led Management”, experts discussed the progression and staging and challenges of autoimmune Type 1 Diabetes, as well as the role of pharmacists as a vital member in the interprofessional care team involved in early detection within community pharmacy settings.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform
 

Partha Kar talks to Steve Edelman, founder of Taking Control Of Your Diabetes, about the role of TCOYD in education and outreach. 

Partha Kar talks to Ezio Bonifacio about the role of islet autoantibody screening programs for the detection of early-stage type 1 diabetes 

Partha Kar talks to Sanjoy Dutta, CSO of Breakthrough T1D, about how to monitor people with IAb positivity. 

An infographic summarising C-peptide, a key biomarker of beta-cell function.

Learn about autoimmune type 1 diabetes (T1D) and the importance of early detection through islet autoantibody (IAb) screening. 

Expert interview highlighting the importance and role of C-peptide during the diagnosis and management of type 1 diabetes 

At the BR1DGE symposium at ESPE-ESE 2025, experts discussed the benefits of early detection of people with presymptomatic type 1 diabetes (T1D) and the practical insights from ongoing T1D screening programs.

This article is intended to be a summary only. Additional topics were covered in the live symposium in line with the applicable regulations but are not included on the BR1DGE platform. 

Clear communication about risks, disease stages, and early detection is a key component of successful T1D screening (Prof. Michael Haller).